| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.wanbury.com | |
| Market Cap | 178.28 Cr. | |
| Enterprise Value(EV) | 233.20 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 21.75 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 2.49 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 33.65 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | -11.02 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | -4.92 | Calculated using Price: 54.20 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 3.27 Cr. | 32,705,498 Shares |
| FaceValue | 10 | |
| About Wanbury Ltd. | ||
| Wanbury was incorporated in 1990 as a private limited company under the name of Pearl Distributors Private Limited. The name of the company was changed to 'Pearl Organics Private Limited on January 17, 1991 and the company was converted into a public limited company on August 6, 1991. | ||
| 1 Day |
|
-4.69% |
| 1 Week |
|
+10.66% |
| 1 Month |
|
+8.53% |
| 3 Month |
|
+46.96% |
| 6 Month |
|
+7.33% |
| 1 Year |
|
-15.38% |
| 2 Year |
|
-47.51% |
| 5 Year |
|
+92.20% |
| 10 Year |
|
+148.62% |
| 9 years | 2014-09 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | ||||||||||
| Return on Capital Employed (%) | -31.06 | 13.85 | 15.27 | 70.48 | -2.00 | 50.26 | 444.45 | 87.61 | 428.79 | |
| Return on Assets (%) | -21.66 | 0.80 | -1.82 | 15.57 | -9.44 | -9.00 | 23.10 | -4.51 | 25.85 |
| Particulars | 10 years | 2014-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | -192 | -194 | -189 | -153 | -185 | -209 | -143 | -156 | -23 | -31 | |
| Non Curr. Liab. | 312 | 298 | 251 | 160 | 106 | 130 | 108 | 84 | 11 | 10 | |
| Curr. Liab. | 259 | 265 | 299 | 402 | 348 | 362 | 311 | 355 | 360 | 360 | |
| Minority Int. | 27 | 27 | 27 | ||||||||
| Equity & Liab. | 406 | 396 | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 338 | |
| Non Curr. Assets | 219 | 215 | 224 | 217 | 192 | 185 | 182 | 182 | 174 | 174 | |
| Curr. Assets | 187 | 181 | 164 | 192 | 78 | 98 | 94 | 98 | 171 | 165 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 406 | 396 | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 338 |
| Particulars | 10 years | 2014-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 662 | 250 | 423 | 434 | 371 | 391 | 367 | 393 | 511 | 501 | |
| Other Income | 11 | 6 | 1 | 90 | 77 | 12 | 46 | 5 | 5 | 4 | |
| Total Income | 673 | 256 | 425 | 524 | 448 | 403 | 414 | 397 | 516 | 505 | |
| Total Expenditure | -638 | -229 | -391 | -415 | -439 | -378 | -389 | -377 | -479 | -479 | |
| PBIDT | 35 | 28 | 34 | 108 | 9 | 25 | 25 | 20 | 37 | 25 | |
| Interest | -48 | -19 | -32 | -36 | -31 | -40 | -33 | -23 | -21 | -19 | |
| Depreciation | -23 | -5 | -9 | -10 | -10 | -10 | -10 | -10 | -11 | -12 | |
| Taxation | -3 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | -89 | 83 | 76 | 76 | |||||||
| PAT | -128 | 3 | -7 | 62 | -32 | -25 | 64 | -13 | 81 | 71 | |
| Minority Interest | |||||||||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | -128 | 3 | -7 | 62 | -32 | -25 | 64 | -13 | 81 | 71 | |
| Adjusted EPS | -64 | 2 | -4 | 27 | -13 | -10 | 26 | -5 | 25 | 22 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 87 | 68 | 40 | 43 | 43 | 32 | 30 | 44 | 17 | 41 | |
| Cash Fr. Inv. | -21 | -6 | -5 | -20 | -13 | -1 | -3 | 64 | 8 | 1 | |
| Cash Fr. Finan. | -64 | -71 | -30 | -28 | -27 | -33 | -27 | -108 | -17 | -29 | |
| Net Change | 3 | -9 | 5 | -5 | 3 | -2 | 0 | 0 | 7 | 13 | |
| Cash & Cash Eqvt | 10 | 1 | 6 | 2 | 5 | 3 | 3 | 3 | 10 | 23 |
|
Wed, 07 Jun 2023
Board Meeting Intimation for Notice For Re-Schedulement Of Board Meeting For Approving Audited Financial Statements And Results Of The Company For The Fourth Quarter And Year Ended 31St March 2023. WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2023 inter alia to consider and approve Further to our letter dated 22nd May 2023 and 25th May 2023 on the captioned subject Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Friday 30th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023. |
|
Wed, 07 Jun 2023
Corrigendum To The Intimation Of The Board Meeting With reference to the above captioned subject and in furtherance to our intimation dated 22nd May 2023 and 25th May 2023 notice is hereby given that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Monday 26th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023.Kindly note the date of the Board Meeting is submitted inadvertently as 30th June 2023 instead of 26th June 2023. |
|
Wed, 07 Jun 2023
Board Meeting Intimation for Notice For Re-Schedulement Of Board Meeting For Approving Audited Financial Statements And Results Of The Company For The Fourth Quarter And Year Ended 31St March 2023. WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2023 inter alia to consider and approve Further to our letter dated 22nd May 2023 and 25th May 2023 on the captioned subject Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Monday 26th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023. |
| Thu, 08 Jun 2023 |
Closing Below Previous Low
|
Close Above Last Week High
|
High Increase in 1 Month
|
High Increase in 3 Months
|
William %R Bearish
|
Equities
M.F.
Sectors
StockEdge Social